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Timing is everything. That’s especially true when it comes to the activation of enzymes created by the pancreas to break down
food. Pancreatic enzymes are packed in secretory granules as precursor molecules called zymogens. In physiological conditions,
those zymogens are activated only when they reach the gut, where they get to work releasing and distributing nutrients that we
need to survive. If this process fails and the enzymes are prematurely activated within the pancreatic cell, before they are released
from the gland, they break down the pancreas itself causing acute pancreatitis. This is a painful disease that ranges from a mild
and autolimited process to a severe and lethal condition. Recently, we demonstrated that the pancreatic acinar cell is able to switch
on a reﬁned mechanism that could explain the autolimited form of the disease. This is a novel selective form of autophagy named
zymophagy, a cellular process to speciﬁcally detect and degrade secretory granules containing activated enzymes before they can
digesttheorgan.Inthiswork,werevisethemoleculesandmechanismsthatmediatezymophagy,aselectiveautophagyofsecretory
granules.
1.Introduction
Autophagyisanevolutionarilypreservedcellularprocessthat
is responsible for the degradation of long-lived proteins and
entire organelles to maintain intracellular homeostasis and
to contribute to starvation and stress responses. Macroau-
tophagy involves the formation of double-membrane
autophagosomes around cargoes, including larger structures
such as organelles and protein aggregates. Autophagosomes
then fuse with lysosomes, where the degradation of the
cargoes takes place. Both nonselective bulk autophagy and
selective autophagy of speciﬁc proteins and organelles have
been described [1]. Genetic analyses in yeast identiﬁed more
than30conservedcomponentsthatarerequiredfordiﬀerent
steps of autophagy (termed Atg genes) [2]. Recently, several
lines of evidence suggest the existence of selective autophagic
degradation pathways in physiology and disease, named,
selective autophagy [3]. During selective autophagy, single
cellular structures, such as protein aggregates and mitochon-
dria are speciﬁcally sequestered by autophagosomes.
There is emerging evidence suggesting the involvement
of ubiquitin in several forms of selective autophagy process.
For example, aggregate clearance by autophagy requires
ubiquitylation and ubiquitin-binding receptors such as
p62 (also known as SQSTM1) [4]. Ubiquitylated artiﬁcial
substrates are recognized by the autophagy machinery and
are speciﬁcally degraded in lysosomes by a p62-dependent
mechanism [5]. Moreover, the selective degradation of
excess ribosomes during starvation depends on the deu-
biquitylation activity of Ubp3/Bre5 [6]. The repertoire
of proteins that participate in these ubiquitin-mediated
pathways during diﬀerent types of autophagy is an area of
intensive investigation, particularly the elucidation of the
role of this speciﬁc cellular program in pathophysiological
processes and complex diseases such as pancreatitis.
Zymophagy is a novel selective form of autophagy that
works as a protective cell response to disease [7]. This new
selective autophagic pathway is activated in pancreatic acinar
cells during pancreatitis-induced vesicular transport alter-
ation, in order to sequester and degrade potentially delete-
rious activated zymogen granules. In this work, we revise the
molecules and mechanisms that mediate zymophagy,as e l f -
eating event that protects the pancreas from self-digestion.2 International Journal of Cell Biology
2. The Disease
2.1. Acute Pancreatitis. Acute pancreatitis, deﬁned as the
pancreas self-digestion, is the most frequent disease of the
pancreas. During pancreatitis, ultrastructural alterations of
zymogen granules are produced in a yet undeﬁned way.
These alterations are characterized by premature activation
of trypsinogen to trypsin within pancreatic acinar cells
leading to the progression of the disease. Most of the cases
are mild acute pancreatitis resulting in a self-limiting disease,
but up to 25% of the patients suﬀers a severe attack and
around 30% of these will die [8]. The pathophysiology
involvesacomplexcascadeofeventsinitializinginpancreatic
acinar cells. An unknown trigger within the pancreas leads
to conversion of digestive proenzymes (zymogens) into their
active form (digestive enzymes), initiating autodigestion
of the gland causing hemorrhage, necrosis, edema, and
complete destruction of pancreatic parenchyma [9]. Chiari
[10], more than a century ago, proposed that autodigestion
by prematurely activated digestive enzymes is responsible for
the onset of this debilitating disease. Although signiﬁcant
research eﬀort has been expended on mechanisms respon-
sible for this premature zymogen activation, many aspects
of the pathogenesis of acute pancreatitis remain enigmatic
(see [11] for a comprehensive review). The presence of
autophagy has been described in dying acinar cells from
human pancreatitis. Helin et al. in 1980 described the
ultrastructural alterations in pancreatic acini from patients
operated for acute necrotizing pancreatitis. They studied by
electronic microscopy those areas of pancreatic parenchyma
that show edematous inﬂammation under light microscopy.
Their ﬁndings in acinar cells included changes in zymogen
granules and an increased autophagocytosis indicated by
several autophagic vesicles [12].
Cholecystokinin (CCK) is a pancreatic secretagogue that
interacts with Gq-coupled receptors in the acinar cell to
induce pancreatic secretion in physiological conditions. On
the other hand, the hyperstimulation of CCK receptors
(CCK-R) with the analogue cerulein that modiﬁes vesicular
transport leads to intracellular proteolytic enzyme activation
and ultimately cell death [13] .T h e s ec e l l u l a re v e n t sa r ec h a r -
acteristic of human acute pancreatitis. Moreover, autophagic
morphological features were also described in cerulein-
induced pancreatitis [14, 15]. Further, the secretagogue-
induced model is the most commonly employed and best
characterized experimental model of acute pancreatitis [16].
Interestingly, early during this experimental model, CCK-R
hyperstimulation activates the selective autophagic degrada-
tionofsecretorygranulesinthepancreaticacinarcell[7,17].
3.TheCells
3.1. The Pancreatic Acinar Cells. The acinar cell of the
exocrine pancreas produces and secretes a wide variety of
potent proteolytic enzymes essential for intestinal digestion
of nutrient proteins. However, these digestive enzymes are
potentially harmful. Therefore, these proteases are produced
as precursors (zymogens) within pancreatic acinar cells and
are only activated in the duodenum. The key step in this
activation process is the conversion of inactive trypsinogen
to active trypsin by limited proteolysis by enteropeptidase, a
highly selective trypsinogen-cleaving protease located at the
luminal site of duodenal cells. The active trypsin initiates an
activation cascade of digestive enzymes within the duode-
num, thereby ensuring the high proteolytic capacity needed
for food digestion. Under pathological conditions that cause
pancreatitis, digestive zymogens undergo premature activa-
tion within the pancreatic acinar cell. High levels of activa-
tion overcome pancreas protective mechanisms, causing cell
injuryandacutepancreatitis[16].However,mostofthecases
of acute pancreatitis are mild and autolimited. Therefore, the
acinar cell may respond to the pathogenic event activating
phenotypically changes that may start defense mechanisms
and explain the autolimited form of the disease [17, 18].
4.TheOrganelles
4.1. Pathologically Activated Zymogen Granules. The pancre-
atic acinar cell is a highly polarized, diﬀerentiated cell whose
primary function is the synthesis and secretion of digestive
enzymes into the pancreatic juice. Pancreatic digestive
enzymes are produced as inactive enzymes (zymogens) and
stored in subcellular structures called zymogen granules,
until exocytosis [16]. Zymogen granules are potentially
harmful secretory granules because once activated, they
release the digestive enzymes within the cell causing cell
death. Thus, they are able to hydrolyze tissue parenchyma
andeventuallytriggeraseveredisease.Theexactmechanisms
of zymogen activation and the complete characterization of
the activation compartments remain unclear [19]. However,
these pathologically altered organelles containing activated
zymogens may be recognized and degraded by a selective
autophagic pathway that we named zymophagy [7].
5.The Molecules
5.1. VMP1. In the search for new molecules that are dif-
ferentially expressed during acute pancreatitis we found a
transmembrane protein that we named Vacuole Membrane
Protein 1 (VMP1) [20]. The in vivo gen expression of
VMP1 in pancreas with pancreatitis correlates with mor-
phological features resembling autophagy [21]. VMP1 is
a transmembrane protein highly activated in acinar cells
early during pancreatitis-induced autophagy, and it remains
in the autophagosomal membrane. We have shown that
VMP1 expression is able to trigger autophagy in mam-
malian cells, even under nutrient-replete conditions [17].
Most of the autophagy-related proteins were described in
yeast or have a yeast homologue. VMP1 does not have
any known homologue in yeast, but its expression is
required to start the autophagic process in mammalian cells
[22]. VMP1 overexpression in mammalian cells induces
the formation of numerous vesicles with ultrastructure
of autophagosomes and they immunostained with LC3,
the widely used marker of autophagosomes. Moreover,
VMP1 expression promotes the conversion of LC3-I to
LC3-II. VMP1 expression in several mammalian cell linesInternational Journal of Cell Biology 3
induces recruitment of LC3 in punctate structures, and that
recruitment is inhibited when VMP1-expressing cells are
treated with the autophagy inhibitor 3-methyladenine (3-
MA).VMP1endogenousexpressionisinducedbyautophagy
stimuli, and its expression is required for autophagosome
development. VMP1 interacts with Beclin 1 through its
hydrophilic C-terminal region, the Atg domain that is essen-
tial for autophagy [17]. Recently, Tian et al. identiﬁed EPG-
3/VMP1 as one of three essential autophagy genes conserved
from worms to mammals, which regulates early steps of
the autophagic pathway in C. elegans [23]. Hierarchical
analyses in mammalian cells by Itakura and Mizushima
[24] show that VMP1 along with ULK1 and Atg14 localize
in the ER-associated autophagosome formation sites in a
PI3-kinase activity-independent manner, conﬁrming the key
role of VMP1 in the formation of autophagosomes. VMP1
expression is induced by extracellular stimuli of autophagy.
For instance, rapamycin, the pharmacological inhibitor of
mTOR and a well-established inductor of autophagy, is able
to activate VMP1 expression, and VMP1-immunostained
vesicles appear in rapamycin-treated cells [17]. Other extra-
cellular stimuli such as gemcitabine in pancreatic cancer
cells [25] and streptozotocine in pancreatic beta cells [26]
induce VMP1 expression and VMP1-mediated autophagy.
VMP1 autophagic vesicles are present in the pancreas of
rats submitted to experimental pancreatitis, showing that
VMP1 is involved in the induction of autophagy during the
disease. Considering that autophagy is implicated in several
pathological mechanisms operating in human diseases, the
activation of the VMP1 pathway may regulate potential
pathophysiological processes involved in the cell response
to disease. We developed the ElaI-VMP1 mouse in which
acinar cell-speciﬁc constitutive expression of a VMP1-EGFP
chimera induces the formation of autophagosomes within
the acinar cell [17]. Thus, the ability of VMP1 expression
to induce autophagy is validated through the development
of this pancreas-speciﬁc transgenic mouse. In the adult
normal pancreas, autophagy and VMP1 are not detected;
in contrast, in VMP1-transgenic mice, multiple VMP1 and
LC3 coimmunostained autophagic structures are present in
pancreas cells. We use this unique tool to investigate the
VMP1 pathway in autophagy during acute pancreatitis [7,
17].
5.2. p62/SQSTM1. Dictyostelium cells lacking Vmp1 gene
show accumulation of huge ubiquitin-positive protein
aggregates containing the autophagy marker Atg8/LC3 and
p62 homologue [27]. The polyubiquitin-binding protein
p62/SQSTM1 is degraded by autophagy. It is found in
cellular inclusion bodies together with polyubiquitinated
proteins and in cytosolic protein aggregates that accumulate
in various chronic, toxic, and degenerative diseases. It
has been shown a direct interaction between p62 and
the autophagic eﬀector proteins LC3A and -B and the
related γ-aminobutyrate receptor-associated protein and γ-
aminobutyrate receptor-associated-like proteins. The bind-
ing is mediated by a 22-residue sequence of p62 containing
an evolutionarily conserved motif. The speciﬁc interac-
tion between p62 and LC3 is instrumental in mediating
autophagic degradation of the p62-positive bodies and p62
is required both for the formation and the degradation of
polyubiquitin-containing bodies by autophagy [4].
5.3. USP9x. Ubiquitination is a covalent posttranslational
modiﬁcation of cellular proteins involving a complex
enzymatic cascade. Emerging evidence suggests that many
enzymes of the ubiquitination cascade are diﬀerentially
expressed or activated in several diseases, including cancer
andmaythereforebeappropriatetherapeutictargets.Protein
ubiquitination is a dynamic two-way process that can be
reversed or regulated by deubiquitinating enzymes (DUB).
The human genome codes for hundred proteins with puta-
tiveDUBactivity[28],whichcanbebroadlydividedintotwo
subgroups: ubiquitin COOH-terminal hydrolase (UCH) and
the ubiquitin-speciﬁc proteases (USP) [29]. USPs comprise
the largest subclass of DUBs in humans, whereas only
four known UCH DUBs have been described [30]. The
USP9x gene is a member of the peptidase C19 family and
encodes for an ubiquitin-speciﬁc protease. Ubiquitinating
anddeubiquitinatingenzymeshaveemergedaskeyplayersin
the regulation of membrane traﬃcking in organisms ranging
from yeasts to mammals [31]( Figure 1).
6.TheSelectiveAutophagicPathway
During acute pancreatitis, the acinar cell activates VMP1-
mediated autophagy. The immunomagnetic isolation of
VMP1-autophagosomes containing zymogen granules from
the EGFP-VMP1 transgenic mouse pancreas with acute
pancreatitis allows the discovery of a new type of selec-
tive autophagy named zymophagy, which functions as an
inducible cellular process that recognizes and degrades
activated zymogen granules [7].
Zymophagy is characterized by the formation of auto-
phagosomes containing zymogen granules. These organelles
mediate the sequestration and degradation of pancreatitis-
activated zymogen granules and are induced by secreta-
gogues and probably other stimuli in acinar cells. Electron
microscopy and immunoﬂuorescence assays in human,
mouse, and cultured pancreatic acinar cells show autophagic
organelles at diﬀerent maturation levels, suggesting that the
autophagic ﬂow progresses to acquire autolysosomal features
and degrades the disease-altered secretory granules. CCK-R
hyperstimulation in wild-type animals induced a markedly
altered distribution pattern of the secretory granules such
as fusion among zymogen granules as well as their fusion
with condensing vacuoles. In addition, acinar cells lose their
polarity, which results in the relocation of zymogen granules
tothebasolateralmembrane.Allthesealterationsinvesicular
traﬃc are known to occur in acinar cells during acute
pancreatitis and upon hyperstimulation of their CCK-R with
cerulein. Surprisingly, ElaI-VMP1 mice subjected to CCK-R
hyperstimulation reveal that acinar cells preserve their struc-
ture and polarity with negligible or no alteration in vesicular
transport. Instead, pancreases from cerulein-treated ElaI-
VMP1 mice present autophagosomes containing zymogen
granulesdisplayingadistinctlocalizationtotheapicalareaof4 International Journal of Cell Biology
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Figure 1: Upon acute pancreatitis, the acinar cell activates Vmp1 gene expression and triggers the autophagic degradation of those zymogen
granules activated during the disease (in red) avowing the intracellular spreading of activated digestive enzymes. Altered zymogen granules
are recognized by ubiquitination. Zymophagy is a novel inducible and selective form of autophagy, mediated by VMP1, which functionally
links the autophagy pathway with the ubiquitin machinery to trigger a protective response to disease.
the acinar cell. These autophagosomes, containing secretory
granules, were easily identiﬁable in apical regions as round
high-density structures within double-membrane vesicles.
After a systematic observation, we did not ﬁnd evidence
of other subcellular structures, such as ribosomes or mito-
chondria, within these autophagosomes. The observation of
diﬀerent maturation levels of selective autophagic vesicles
as well as the degradation of p62 provides evidence that
autophagic ﬂow remains primarily unchanged under CCK-R
hyperstimulation. Interestingly, similar to the case of in vivo
autophagosomes, in vitro CCK-R hyperstimulation of ElaI-
VMP1 mouse isolated acini induces a subcellular change in
VMP1-containing autophagosomes to the zymogen granule-
richarea(apicalpole),therefore,inacinarcellsfromtheElaI-
VMP1 mice, CCK-R hyperstimulation induces a progressive
ﬂowofautophagicvesiclescontainingzymogengranulesthat
accumulate at the apical pole of acinar cells [7].
The distinctive characteristic of VMP1 as an autophago-
some transmembrane protein allows the isolation of auto-
phagosomes from pancreas tissue of treated and untreated
ElaI-VMP1 mice. Autophagosomes containing zymogen
granules are magnetically immunopuriﬁed from the pan-
creas of ElaI-VMP1 mice treated with cerulein, whereas in
untreated animals, either empty or cytoplasm-containing
autophagosomes are puriﬁed. In untreated animals, less than
20% of the autophagosomes contains zymogen granules,
whereasintheceruleintreatedones,thispercentageincreases
up to 70%. LC3-II is present in autophagosomal frac-
tions from both cerulein-treated and untreated specimens.
Notably, strong signals of p62 and trypsinogen are found
only in magnetically immunopuriﬁed autophagosomes from
cerulein-treated ElaI-VMP1 mice. This ﬁnding suggests that
p62, which is an ubiquitin-binding protein that interacts
with LC3 [4], may function as a cargo receptor during
the selective autophagic pathway. Therefore, a nonselective
autophagy pathway, which involves LC3-II but not p62, is
triggered by VMP1 expression in untreated mouse pan-
creases. On the other hand, upon CCK-R hyperstimulation,
p62 is involved in VMP1-mediated selective autophagy of
zymogen granules. The description of zymophagy positions
VMP1 and p62 in the same selective autophagy pathway.
Immunoﬂuorescenceassaysandwesternblotanalysesofpro-
teins from isolated selective autophagosomes demonstrate
that these proteins colocalize and coexist in this autophagic
organelle suggesting that p62 may act as cargo receptor
during VMP1-selective autophagic pathway [7].
Zymophagyselectivelydegradesactivatedzymogengran-
ules. The intracellular activation of trypsinogen induced
by hyperstimulation of CCK-R in isolated murine pan-
creatic acini can be detected using rhodamine 110 bis-
(CBZ-L-isoleucyl-L-prolyl-L-arginine amide) dihydrochlo-
ride (BZiPAR), a cell permeable substrate that becomes
ﬂuorescent after the cleavage by the protease [32]. Upon
CCK-R hyperstimulation, acinar cells from wild-type mice
show early cytoplasmic trypsinogen activation, which is a
hallmark of pancreatitis pathophysiology. Surprisingly, in
acinar cells from ElaI-VMP1 mice, CCK hyperstimulation
causes almost no activation of trypsinogen. Microscopic
examinations reveal only few activated granules that highly
colocalize with the VMP1-EGFP ﬂuorescent signal showing
that zymophagy selectively sequester the activated zymogen
granules. Zymogen activation is an enzymatic chain reaction
where initial zymogen granule alterations trigger rapid
spread of active trypsin within the acinar cell. We think
that the degradation of early-activated zymogen granules
by zymophagy prevents this deleterious event. Interestingly,
the inhibition of autophagic ﬂow markedly increased trypsin
activity within acinar cells in ElaI-VMP1 mouse pancreases
underCCK-Rhyperstimulation,conﬁrmingthatzymophagy
speciﬁcallydegradesthosezymogengranulesthatareinitially
activated by acute pancreatitis. This function of zymophagy
is evident in the in vivo animal model of acute pancreatitis,
where the hability of the ElaI-VMP1 mouse developing
zymophagy clearly prevents the increment of enzymatic
markers of pancreatic damage and pancreas morphological
changes characteristic of acute pancreatitis.
Zymophagy speciﬁcally recognizes the pathologically
activated zymogen granules. During zymophagy, the ubiqui-
tin system serves as a targeting signal for zymogen granules.
Proteins involved in the recognition of target for autophagyInternational Journal of Cell Biology 5
are ubiquitin-binding proteins, such as p62 that binds
directly to ubiquitin and LC3. Magnetically puriﬁed VMP1-
mediated autophagosomes upon CCK-R hyperstimulation
contain p62 and LC3 proteins and high colocalization of
ubiquitin with amylase and with trypsinogen occurs early
after CCK-R hyperstimulation. Moreover, the recruitment
of ubiquitin with LC3, and the ubiquitin signal within LC3
decorated vesicles along with the colocalization between
VMP1 and ubiquitinated granules, and the engulfment
of ubiquitinated granules by VMP1-vesicles, demonstrate
the selective sequestering of ubiquitinated zymogen gran-
ules by zymophagy [7]. More important, the selectively
sequestered ubiquitinated granules are those activated by
CCK-R hyperstimulation. GFP-Ub-transfected acinar cells
subjected to CCK-R hyperstimulation show colocalization
between activated granules and ubiquitin aggregates but
do not show colocalization with unaﬀected or normal
zymogen granules, indicating that the ubiquitin system
serves as a targeting signal for activated zymogen granules
during zymophagy. Therefore, activated zymogen granules
are directly or indirectly ubiquitinated for their recogni-
tion by autophagic membranes, in which ubiquitin acts
as a label for selective engulfment. This label might be
subsequently removed for completing the formation of
the autophagosome or even before this engulfment step.
Nevertheless, activated zymogen granules are ubiquitinated
upon acute pancreatitis and the VMP1-mediated selective
autophagic pathway sequesters these ubiquitinated granules
[7].
Notably, the ubiquitin-speciﬁc protease USP9x is showed
to be an essential component of the machinery required to
selectively degraded zymogen granules during zymophagy
[7]. USP9x expression is highly induced in pancreatic
acinar cells under CCK-R hyperstimulation. Also, USP9x
is required to promote the selective degradation of altered
zymogengranules.Interestingly,VMP1interactswithUSP9x
early during zymophagy, supporting a direct functional
role for this ubiquitin-speciﬁc protease in this selective
autophagicpathway.Furthermore,downregulationofUSP9x
abolished activated zymogen granule degradation in aci-
nar cells under CCK-R hyperstimulation, conﬁrming the
essential role of VMP1-USP9x interaction for zymophagy.
USP9x is likely to modulate zymogen granule selective
engulfment during acute pancreatitis by modulating VMP1
or providing a preferential recognition signal for altered
zymogen granules. This data demonstrates for the ﬁrst
time that ubiquitin modiﬁcations may possess an additional
function in acinar cells by promoting the degradation of
highly harmful activated zymogen granules and strongly
support the idea that there is a close cooperation between the
autophagy pathway and the ubiquitin machinery required
for selective autophagy. Alternatively, both ubiquitination
and deubiquitination of distinct critical molecules might be
required for selective autophagy. Thus, due to the potential
importance of this type of regulation, these ﬁndings may fuel
futureinvestigationsaimedtoidentifythepotentialE3ligases
a n du b i q u i t i n a t e ds u b s t r a t e ( s )r e q u i r e df o rz y m o p h a g y .
Zymophagypreventspancreaticacinarcelldeathinduced
by CCK-R hyperstimulation [7]. Autophagosome formation
inhibition with 3-methyl adenine as well as autophagy ﬂux
interruption with vinblastine signiﬁcantly reduces acinar
cell survival in a cell model of acute pancreatitis. More-
over, VMP1 downregulation (shVMP1) also signiﬁcantly
decreased acinar cell survival under CCK hyperstimulation
showing that VMP1 expression is required to prevent acinar
cell death in acute pancreatitis. These results indicate that
zymophagy prevents pancreatic cell death induced by the
activation of zymogen granules [33] and conﬁrm that
endogenous VMP1 expression is activated in acinar cells to
mediate zymophagy as a protective cellular response against
cell death.
Furthermore, VMP1 expression and zymophagy are
present in human pancreas aﬀected by acute pancreatitis [7].
VMP1 is not detectable in human normal pancreas tissue,
butitsexpressionisactivatedinhumanpancreatitispancreas
specimens and highly colocalizes with LC3 in autophago-
somes. Moreover, autophagosomes markedly colocalize with
zymogengranules.Remarkable,theﬁndingoflargeautolyso-
somes without trypsin signal in human pancreatitis pancreas
supports the experimental data and suggests that aﬀected
zymogen granules are eventually degraded by zymophagy
during human pancreatitis. Results collectively demonstrate
a previously unrecognized function for VMP1, mediating
zymophagy, a novel selective form of autophagy, which
functionally links the autophagy pathway with the ubiquitin
machinery to trigger a protective cell response to disease.
7. The Function
The description of zymophagy provides further under-
standing of the autophagy molecular mechanisms relevant
to human diseases, particularly acute pancreatitis. This
condition has classically been considered an autodigestive
disorder where the inappropriate activation of trypsinogen
within the pancreatic acinar cell leads to the progression
of the disease. The exact mechanism for the initiation of
zymogen granule activation remains a subject of inten-
sive investigation and debate [11]. Similarly, the role of
autophagy in pancreatitis is seemingly incomplete, some-
times contradictory and requires further investigations. For
instance, Hashimoto et al. [34] propose that autophagy is
responsible for the zymogen activation within the acinar
cell in acute pancreatitis. This suggestion is mainly based
on the ﬁnding that deletion of the Atg5 gene in mouse
pancreatic cells seems to prevent morphological alterations
induced by CCK-R hyperstimulation. However, cells lack-
ing Atg5 and Atg7 can still perform autophagy-mediated
protein degradation [35], showing that deletion of these
genes does not completely abolish autophagy. Moreover,
no selective autophagic features were reported in the LC3
transgenic mouse pancreas after 48 hours starvation [36].
However, the induction of autophagy by starvation did not
promote any morphological evidence of acute pancreatitis
[36].Interestingly,VMP1constitutiveexpressioninducesthe
formation of autophagosomes in acinar cells but does not
trigger pancreatitis [7, 17]. On the other hand, Mareninova
et al. [37] have proposed that lysosomal proteases cathepsin6 International Journal of Cell Biology
L and B are reduced, suggesting a defect in the autophagic
ﬂow during acute pancreatitis. These data also introduce the
question whether the role of diﬀerent types of autophagy
has an impact on pancreatitis. In this regard, zymophagy
is an inducible form of selective autophagy activated in
responsetodisease.Zymophagyisnotinducedbystarvation;
it is triggered by CCK-R hyperstimulation and mediated
by VMP1-USP9x-p62 autophagy-ubiquitin pathway [17].
This selective form of autophagy sequesters and degrades
activated zymogen granules and prevents acinar cell death.
Therefore, the outcome of pancreatitis diﬀers when diﬀerent
types of autophagy pathways are considered, including
selective and nonselective ones.
8.The Meaning
For the ﬁrst time, it was demonstrated that there is activation
of the VMP1-autophagic pathway and a selective autophagy
of secretory granules during human pancreatitis [7]. These
ﬁndings lead us to discuss how this knowledge ﬁts the
current theoretical framework regarding the occurrence and
progression of this disease. Acute pancreatitis is a frequent,
painful, and often deadly disease that ranges from a mild,
edematous, and autolimited process, to a severe necrotizing
and eventually lethal condition. Additionally, the etiology
of this disease is diverse, and diﬀerent stimuli can initiate
the same autodigestion cascade via diﬀerent mechanisms.
VMP1 expression is activated during acute pancreatitis in
humans, and there is formation of autophagosomes where
p62, LC3, and zymogen granules colocalize [7]. The selective
autophagic degradation of zymogen granules (Zymophagy)
is a protective cell response that could explain, at least in
part, the autolimited form of this disease seen in many
patients. Hence, it is tempting to speculate that the more
eﬃcient zymophagic response by the pancreatic acinar cell,
the less severity of the disease. In contrast, severe forms of
pancreatitis oﬀering an excess of cargo and an accelerated
rate of degradation might overcome or disrupt the protective
capacity of this selective autophagic process. The latter
possibility is suggested by our studies since the inhibition of
theautophagicﬂowimpairstheprotectiveroleofzymophagy
[17]. Interestingly, Fortunato and Kroemer [38] ﬁndings,
regarding the reduction of the autophagosomelysosome
fusion in human alcoholic pancreatitis, further support our
hypothesis.
Finally, this novel autophagic pathway that selectively
degrades altered secretory granules might be involved in
other pathological processes aﬀecting secretory cells, such as
pancreatic beta cells in diabetes mellitus [26]o rP a n e t hc e l l s
in Chron’s disease [39]. Therefore, more studies on selective
autophagy as a programmed cell response to pathological
processes that aﬀect protein secretion are important to
signiﬁcantly expand our knowledge of the role of autophagy
in both cell biology and human disease.
9. Conclusions
Zymophagy revels a critical function of autophagy in
secretory granule homeostasis and cell response to injury.
It consists in the selective degradation of disease-induced
activated secretory granules. This process can be recon-
structed by the hyperstimulation of Gq-coupled receptors
with CCK in a transgenic mouse model for studying VMP1-
induced autophagy in pancreatic acinar cells (ElaI-VMP1
mice). A VMP1-USP9x-p62 molecular pathway is involved
inthisselectiveautophagicprocess.Zymophagydegradesthe
activated granules avoiding the spreading of their contents
into the cytoplasm, thus preventing further trypsinogen
activation and cell death.
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